Indices
MAYBAKER
| Price | Today's Change | Avg daily Volume | 1 Year Change | 52 Week Range |
|---|---|---|---|---|
| 16.50 | 0.00 (0.00%) | 598.79K | 8.50 (106.25%) | 6.70 - 19.50 |
Data in real-time, as of 12/14/2025 5:41:15 PM
3 Months Trend
Profile
May & Baker Nigeria Plc engages in the manufacture, sale, and distribution of human pharmaceuticals and vaccines, and food and beverage products in Nigeria. Its product line includes cough and cold preparations, anti histamines, sulphonamides, anti-amoebicides, anti-malarials, anti-dibiaetics, analgesics, anti-hypertensives, and antibiotics. The company also offers noodles under the Mimee brand name; and water under the Lily brand name. May & Baker Nigeria Plc was founded in 1944 and is headquartered in Lagos, Nigeria. Website: www.may-baker.com Founded in: 1944
Quotes
| LClose | 16.50 | Price | 16.50 |
|---|---|---|---|
| Change | 0.00 (0.00%) | Low | 16.50 |
| High | 16.50 | EPS | 0.14 |
| 52WkHigh | 19.50 | 52WkLow | 6.70 |
| 50d Mov Avg | 17.18 | 200d Mov Avg | 14.42 |
| AvgDlyVol | 598.79K | 3MthChg | 0.25 (1.54%) |
| 6MthChg | 1.10 (7.14%) | 12MthChg | 8.50 (106.25%) |
| Beta | 0.7760811 | Risk Factor | 0.0269331 |
| PE | 58.94 | Shares Outs. | 1.73B |
| Div. Yield | 3.75 | Market Cap | 28.47B |
| Volume | 243.31K | # Of Trades | 57 |
| Trades Value | 4.17M | ||
| Sector | Pharmaceuticals | ||
Income statement
Statement of Comprehensive Income as at
31-Mar-2018
| Name | Amount |
|---|---|
| Revenue | 8,552,163.00 |
| Profit before taxation | 817,912.00 |
| Taxation | -475,226.00 |
| Profit/(loss) after tax | 342,686.00 |
| Transfer to revenue reserve | 342,686.00 |
| Profit attributable to: | |
| Owners of the company | 342,686.00 |
| Non-controlling interest | |
| Earnings per 50k share (k) | 35.00 |
| Net assets per 50k share (k) | 4.00 |
Board of directors
| Name | Title |
|---|---|
| Theophilus Danjuma | Non-Executive Chairman |
| Nnamdi Okafor | Managing Director/Chief Executive Officer, Executive Director |
| Ayodeji Aboderin | Financial Controller/Chief Financial Officer |
| Ezekiel Ibidapo | Pharmaceutical Manufacturing Operations, Executive Director |
| Valentine Okelu | General Manager/Head, Foods Division |
| Chukutem Chukuka | Head, Pharma Sales and Marketing |
| Gladys Umoh | Head, Human Capital Development |
| Edudie Abebe | Non-Executive Director |
| Adebayo Adeleke | Non-Executive Director |
| Ishaya Dankaro | Non-Executive Director |
| Gloria Odumodu | Non-Executive Director |
Currency
| Currency | Rate(₦) |
|---|---|
| USD USD/NGN | 1,452.65 |
| GBP GBP/NGN | 1,945.59 |
| CAD CAD/NGN | 1,054.29 |
| CNY CNY/NGN | 205.81 |
| AUD AUD/NGN | 967.82 |
| XOF XOF/NGN | 2.60 |
| XAF XAF/NGN | 2.60 |
| GHS GHS/NGN | 126.47 |
| AED AED/NGN | 395.55 |
| ZAR ZAR/NGN | 86.14 |
| JPY JPY/NGN | 9.34 |
| KES KES/NGN | 11.27 |
| EGP EGP/NGN | 30.56 |
| INR INR/NGN | 16.10 |
| AUD AUD/NGN | 967.82 |
| CHF CHF/NGN | 1,827.98 |
| DZD DZD/NGN | 11.20 |
| MAD MAD/NGN | 157.95 |
| AOA AOA/NGN | 1.59 |
| TZS TZS/NGN | 0.59 |
| BWP BWP/NGN | 109.71 |
| ETB ETB/NGN | 9.33 |
| NAD NAD/NGN | 85.72 |
| SDG SDG/NGN | 2.42 |
| MZN MZN/NGN | 22.73 |
| SLL SLL/NGN | 0.07 |
| MWK MWK/NGN | 0.84 |
| BIF BIF/NGN | 0.49 |
| GNF GNF/NGN | 0.17 |
| LRD LRD/NGN | 8.21 |
| SZL SZL/NGN | 85.73 |
| CVE CVE/NGN | 15.43 |
| RWF RWF/NGN | 1.00 |
| DJF DJF/NGN | 8.17 |
| ERN ERN/NGN | 96.84 |
| ZMW ZMW/NGN | 62.84 |
